Skip to content

Addiction: all studies

Page 547 of 863: studies 5,461 to 5,470 of 8,627, newest first. Back to the addiction overview

Research

A pilot study of Vipassana meditation with female drug users at a rehabilitation centre, Thailand

Therapeutic Communities: The International Journal of Therapeutic Communities November 28, 2019 Nualnong Wongtongkam, Phrakhru Bhavanaveeranusith

Purpose Substance abuse has become a major health issue in Thailand, contributing to high numbers of premature deaths and requiring considerable expenditure on treatment and rehabilitation programs. The purpose of this paper is to explore use of Vipassana meditation to reduce depression and improve empathy and self-awareness in drug dependent women at a rehabilitation centre....

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans

Translational Psychiatry November 18, 2019 Zhongshan Cheng, Chureerat Phokaew, Yi-Ling Chou et al. 4 citations

Abstract Cannabis, the most widely used illicit drug, can induce hallucinations. Our understanding of the biology of cannabis-induced hallucinations (Ca-HL) is limited. We used the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) to identify cannabis-induced hallucinations (Ca-HL) among long-term cannabis users (used cannabis ≥1 year and ≥100 times). A genome-wide...

DOI: 10.1038/s41398-019-0639-7 (opens in new tab) Full text (opens in new tab) Cannabis Genome-wide association study Meta-analysis Single-nucleotide polymorphism +3

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Neuropsychopharmacology November 16, 2019 Friederike Holze, Patrick Vizeli, Felix Müller et al. 250 citations

Abstract Lysergic acid diethylamide (LSD) is a classic psychedelic, 3,4-methylenedioxymethamphetamine (MDMA) is an empathogen, and d -amphetamine is a classic stimulant. All three substances are used recreationally. LSD and MDMA are being investigated as medications to assist psychotherapy, and d -amphetamine is used for the treatment of attention-deficit/hyperactivity disorder. All three...

Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization

Psychopharmacology November 15, 2019 Michael D. Berquist, Sebastian Leth-Petersen, Jesper L. Kristensen et al.

There is a renewed interest in the use of 3,4-methylenedioxymethamphetamine (MDMA) for treating psychiatric conditions. Although MDMA has entered phase II clinical trials and shows promise as an adjunct treatment, there is an extensive literature detailing the potential neurotoxicity and adverse neurobehavioral effects associated with MDMA use. Previous research indicates that the adverse...

WHAT KIND OF HEALING DOES PSYCHEDELIC-ASSISTED PSYCHOTHERAPY FOSTER?

PEOPLE: International Journal of Social Sciences November 15, 2019 Candice L Shelby

World-wide, researchers and practitioners in psychiatry are increasingly interested in the effectiveness of such substances as MDMA, LSA, and psylocibin in treating such disorders as addiction, post-traumatic stress disorder, and other types of depressive and anxiety. Although most of these substances were declared illegal in most countries during the 1970s, research into their use was...

AYAHUASCA: COMMERCE ÉQUITABLE FOR THE EMPOWERMENT AND PROTECTION OF INDIGENOUS PEOPLE’S INTELLECTUAL PROPERTY RIGHTS

Revista Brasileira de Direito Animal November 14, 2019 M. Pereira, S. A. Mello

Ayahuasca is a psychoactive beverage commonly consumed by indigenous people of the Amazon, traditionally used in religious and medicinal rituals. Nowadays, the infusion is often consumed by non-indigenous people due to its popularization. Scientific research corroborates the indigenous belief on the beverage’s healing powers when it comes to psychoneurological disorders. It is verified that a...

Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms

Angewandte Chemie International Edition November 14, 2019 Claudius Lenz, Jonas Wick, Daniel Braga et al. 56 citations

Abstract Upon injury, psychotropic psilocybin‐producing mushrooms instantly develop an intense blue color, the chemical basis and mode of formation of which has remained elusive. We report two enzymes from Psilocybe cubensis that carry out a two‐step cascade to prepare psilocybin for oxidative oligomerization that leads to blue products. The phosphatase PsiP removes the 4‐ O ‐phosphate group to...

DOI: 10.1002/anie.201910175 (opens in new tab) Magic telescope Magic bullet Bioinformatics

Respiration

November 13, 2019 Robin van Löben Sels

This chapter begins with definitions and the history of the attribute of respiration as it has always related to the mystery of the breath, which in turn is associated with life and death and, as life force, connected to spirit and soul. Connections are explored between the breath and instinctual expression of strong affects, and connections with the inspirations of the inner world and the...

Sustainable Intensification of Sorghum and Pearl Millet Production by Seed Priming, Seed Treatment and Fertilizer Microdosing under Different Rainfall Regimes in Mali

Agronomy November 12, 2019 Adama Coulibaly, Kamkam Woumou, Jens B. Aune

Sorghum and pearl millet are the most important stable crops in the drylands of West Africa. This four-year study based on two experiments assessed different low-cost methods for intensification of sorghum and millet production under contrasting rainfall conditions in Mali. Experiment 1 assessed the microdosing rates 0, 0.2, 0.4, 0.6 and 0.8 g NPK hill−1 combined with seed priming across four...

Nightmares share strong genetic risk with sleep and psychiatric disorders

bioRxiv (Cold Spring Harbor Laboratory) November 9, 2019 Hanna M. Ollila, Nasa Sinnott-Armstrong, Katri Kantojärvi et al. 5 citations preprint

ABSTRACT Nightmares are vivid, extended and extremely dysphoric dreams that awaken the dreamer. Twin studies indicate that nightmare frequency has a heritability between 36 and 51% providing evidence for genetic factors underlying predisposition to nightmares. Furthermore, while cross-sectional epidemiological findings suggest that heavy alcohol usage, traumatic experiences and psychiatric...

DOI: 10.1101/836452 (opens in new tab) Full text (opens in new tab) Nightmare Neuroticism Mendelian randomization Sleepwalking +10